首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1171403

胎兒·新生兒用醫療設備的全球市場預測(2022年～2027年)

Fetal & Neonatal Care Equipment Market - Forecasts from 2022 to 2027

出版日期: 2022年10月25日 | 出版商:

Knowledge Sourcing Intelligence | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球胎兒·新生兒用醫療設備的市場規模在2020年估算為85億7,400萬美金，在預測期間內預計將以6.17％的年複合成長率增長，成為2027年末為止為130億3,400萬美元。市場成長的主要因素有全球早產率上升、先天性疾病患病率上升以及技術進步帶來的先進系統的可用性等。

本報告提供全球胎兒·新生兒用醫療設備市場相關調查，提供市場規模和預測，COVID-19影響，市場促進因素及課題，市場趨勢，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

簡介
北美
- 美國
- 加拿大
- 墨西哥
南美
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 義大利
- 其他
中東·非洲
- 阿拉伯聯合大公國
- 以色列
- 沙烏地阿拉伯
- 其他
亞太地區
- 日本
- 中國
- 印度
- 韓國
- 泰國
- 台灣
- 印尼
- 其他

第9章競爭環境與分析

主要企業策略分析
新興企業與市場的有利性
合併，收購，契約，合作
供應商的競爭矩陣

第10章企業簡介

Aspect Imaging Ltd.
General Electric Company
EMCO Meditek Pvt. Ltd.
Fisher & Paykel Healthcare Limited
Masimo Corporation
Natus Medical Incorporated
Phoenix Medical Systems(P)Ltd.
Dragerwerk AG & Co. KGaA
Spacelabs Healthcare(OSI Systems, Inc.)
Becton, Dickinson and Company

簡介目錄

Product Code: KSI061611882

The global fetal & neonatal care equipment market is estimated to surge at a CAGR of 6.17% from a market value of USD8.574 billion in 2020 to achieve a market value of USD13.034 billion by the end of 2027. Fetal & neonatal care equipment, whether, for monitoring, treatment, or diagnostic purposes, offers care to a newborn or an unborn fetus diagnosed with a medical condition. These pieces of equipment comprise phototherapy equipment, incubators, cardiopulmonary monitors, umbilical catheters, pulse oximeters, and many more. The market is projected to grow at a fast pace with the growing preterm birth rates at the global level. The growing incidences of congenital diseases are further augmenting the market demand during the forecast period. The availability of advanced systems due to technological advancements is further providing an impetus to fuel the market growth over the next five years. Additionally, growing fertility tourism demands state-of-the-art equipment for monitoring fetal and newborn health is further providing an opportunity for the market to propagate during the forecast period. Rising cesarean births are further propelling the market demand in the forecast period. Concerns about the increased risk of complications during pregnancy and delivery for mothers over the age of 35 provide an additional opportunity for the market to expand during the forecast period.

Geographically, North America is projected to hold a significant market share in the forecast period owing to the advanced healthcare facilities for mothers and their newborns. The highest health expenditure in the United States is further contributing to surging market growth in the forecast period. The shift from volume-based care to value-based care is further offering strong market growth prospects in the forecast period. On the other hand, the Asia Pacific region is projected to experience high growth during the forecast period due to rising awareness regarding efficient care during pregnancy and at the time of delivery. Also, significant initiatives to provide efficient healthcare services to mothers and their newborns are further augmenting the market demand in the forecast period.

COVID-19 Impact on Fetal & Neonatal Care Equipment Market

Companies in the fetal and neonatal care businesses are trying their best to monitor the situation closely and are ready to assess any impact on supply and daily operations. Organizations are dealing with difficulties as a result of lockdown and work-from-home policies, causing material and limit issues with a portion of the providers. As a result of some degree of disruption causing shipment deferrals to clients, the market is expected to experience a slight decline in the midst of the Coronavirus.

The growing popularity of fertility tourism will continue to proliferate the market demand during the course of the forecast period.

Fertility treatments, also known as cross-border reproductive care (CBRC), are gaining popularity at the global level where people, including infertile couples, and single, gay, or transgender individuals are seeking effective fertility treatments outside of their home countries. The major reasons for the adoption of reproductive treatments abroad include legal restrictions and the high cost of treatment in their home countries. Also, among other reasons, quality of care, i.e., success rate and long waits, and sociocultural considerations play a significant role in choosing fertility treatments abroad. The most common forms of fertility treatments involve in vitro fertilization, intracytoplasmic sperm injection, sperm donation, egg donation, and fertility preservation, among others.

Growing infertility among males and females worldwide is one of the major factors driving fertility tourism. In the United States, it has been observed that around 10% of women aged between 15 and 44 years of age are experiencing difficulty in conceiving or staying pregnant. On an international level, it has been estimated that over 8% of couples are affected by fertility issues. It has further been analyzed that out of all the infertility cases, close to 50% of them are affecting males. Hence, with this, the market is projected to show strong prospects for growth along with a greater demand for reproductive care. Infertility in males is due to specific medical conditions like diabetes, thyroid disorders, genetic disorders, and hormonal imbalances, among others. For females, infertility arises due to the adoption of unhealthy living conditions like smoking, being active or passive, being obese or overweight, exposure to chemicals, and mental stress, among others.

The rising number of cesarean sections provides another opportunity for the market to thrive during the forecast period.

It has been widely noted that the rate of C-sections is growing at a rapid pace. Furthermore, it has been observed that the rate of cesarean has exceeded the number of vaginal deliveries in the regions of China, Southeast Europe and Latin American countries. Even in less-developed nations, the rate of C-sections is quite high. For instance, in Bangladesh, less than 60% of births are known to occur in clinics, and of those, around 65% are C-sections. Hence, the market is provided with considerable growth opportunities with rising cesarean deliveries.

The global and regional increase in the adoption of cesarean section is attributed to the growing proportion of births taking place in healthcare facilities along with the increase in cesarean use in these health facilities.

It was further noticed that cesarean section usage was more prevalent in the richest countries than the poorest in low-income and middle-income countries. Furthermore, high C-section use was observed among individuals with low obstetric-risk births, particularly among educated females. For instance, in Brazil and China, the C-sections were estimated to be around 1.6 times more frequently performed in a private healthcare setting than in a public healthcare setting. The adoption of C-sections will require constant monitoring of the foetus and the newborn after delivery as a part of the C-section planning, further augmenting the market demand in the forecast period.

The adoption of C-sections will necessitate continuous monitoring of the foetus and newborn after delivery as part of the C-section planning, which will increase market demand during the forecast period. The WHO proposed rate for C-sections is 10-15%. It has been recommended that the annual rate should decline in low-risk females from the current rate of around 27-24%. In the United States, the rate is much higher, at around 32%.

Recent Developments

In May 2021, a Team of researchers led by Northwestern University and The University of North Carolina at Chapel Hill developed First Wireless Sensors to Monitor Pregnant Women and their Babies. The new wearable devices monitor the mother's and baby's vital signs while also providing new data, such as information on the mother's physical movements and labouring positions.
PulseNmore introduced the world's first self-administered handheld tele-ultrasound device in August 2020. It allows pregnant women to perform at-home ultrasound scans and receive feedback from a doctor or sonographer, reducing the need for hospitalisation.
Philips launched the Avalon CL Fetal and Maternal Pod and Patch in June 2020 to aid in foetal and maternal monitoring. This device monitors maternal heart rate, foetal heart rate, and uterine activity continuously and non-invasively by applying a single-use, 48-hour disposable electrode patch to the mother's abdomen.

Market Segmentation:

By Type

Fetal Care

Neonatal Care

By Product

Monitors

Treatment Equipment

Diagnostic Equipment

By End-User

Hospitals

Clinics

Research Centers

By Geography

North America

USA
Canada
Mexico

South America

Brazil
Argentina
Others

Europe

UK
Germany
France
Italy
Others

Middle East and Africa

UAE
Israel
Saudi Arabia
Others

Asia Pacific

Japan
China
India
South Korea
Thailand
Taiwan
Indonesia
Others

1. Introduction

1.1. Market Overview
1.2. Covid 19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. Research Methodology

2.1. Research Data
2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Fetal & Neonatal Care Equipment Market Analysis, by Type

5.1. Introduction
5.2. Fetal Care
5.3. Neonatal Care

6. Fetal & Neonatal Care Equipment Market Analysis, by Product

6.1. Introduction
6.2. Monitors
6.3. Treatment Equipment
6.4. Diagnostic Equipment

7. Fetal & Neonatal Care Equipment Market Analysis, by End-User

7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Research Centers

8. Fetal & Neonatal Care Equipment Market Analysis, by Geography

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. UK
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. UAE
- 8.5.2. Israel
- 8.5.3. Saudi Arabia
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Thailand
- 8.6.6. Taiwan
- 8.6.7. Indonesia
- 8.6.8. Others